Colorectal cancer is a serious health issue. Many people ask if capecitabine is a good choice for treatment. A recent study looked at the cost and benefits of this drug compared to active monitoring. The study focused on patients with stable or responding metastatic colorectal cancer after 16 weeks of initial treatment. Capecitabine is a chemotherapy drug. It is oft...

When it comes to treating unresectable hepatocellular carcinoma (uHCC), a type of liver cancer, lenvatinib is often the go-to treatment. But how does it stack up against other options? Researchers used a clever method called inverse probability of treatment weighting (IPTW) and network meta-analysis (NMA) to compare lenvatinib with other treatments that are either ap...